Quarterly report · Q1
2160.TEDINET S100QRIK
Period2023-01-01 → 2023-03-31
Filed2023-05-15
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2023-01-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥17.4bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥3.9bn | 2022-01-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Operating income | ¥398m | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥479m | 2022-01-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥65m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥768m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥347m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥3m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥389m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥351m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥342m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | −¥868m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥72m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥34.1bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥33.9bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥32.6bn | at 2022-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥14.3bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥14.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥19.8bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥20.5bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.3bn | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥21.2bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥21.0bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥20.3bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥10.6bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.0bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.4bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥710m | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥393m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥426m | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥1.2bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.1bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥298m | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥52m | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥646m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥331m | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-0.06 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥8.19 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥7.4 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-0.06 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥8.11 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥7.36 | 2022-01-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 62.2% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.8% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.4% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 22
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | −¥23m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥623m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥600m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥23m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥248m |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥3.6bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥3.6bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥149m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥4.2bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥4.2bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥23m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥398m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥532m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥532m |
| jpcrp040300-q1r_E05712-000Medical Devicereportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥255m |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥3.4bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥3.4bn |
| jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥224m |
| —segment total | revenue | 2022-01-01 → 2022-03-31 | ¥3.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-03-31 | ¥3.9bn |
| —segment total | segment profit | 2022-01-01 → 2022-03-31 | ¥479m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 547
| Item | Context | Value | Unit |
|---|---|---|---|
| Issuance of new shares ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | - | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_ShareCapitalIFRSMember | - | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_CapitalSurplusIFRSMember | - | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_TreasurySharesIFRSMember | - | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_RetainedEarningsIFRSMember | - | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_ShareAcquisitionRightsIFRSMember | -21725000 | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | - | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | -21725000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_ShareCapitalIFRSMember | - | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_CapitalSurplusIFRSMember | - | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_TreasurySharesIFRSMember | - | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_RetainedEarningsIFRSMember | - | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_ShareAcquisitionRightsIFRSMember | 50245000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | - | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | 50245000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_ShareCapitalIFRSMember | 1837000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_CapitalSurplusIFRSMember | 1837000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_TreasurySharesIFRSMember | - | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_RetainedEarningsIFRSMember | - | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_ShareAcquisitionRightsIFRSMember | 28520000 | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | - | JPY |
| Total transactions with owners IFRS | CurrentYTDDuration_OtherComponentsOfEquityIFRSMember | 28520000 | JPY |
| Equity IFRS | CurrentQuarterInstant_ShareCapitalIFRSMember | 10894908000 | JPY |
| Equity IFRS | CurrentQuarterInstant_CapitalSurplusIFRSMember | 6235224000 | JPY |
| Equity IFRS | CurrentQuarterInstant_TreasurySharesIFRSMember | -756000 | JPY |
| Equity IFRS | CurrentQuarterInstant_RetainedEarningsIFRSMember | 693486000 | JPY |
| Equity IFRS | CurrentQuarterInstant_ShareAcquisitionRightsIFRSMember | 852712000 | JPY |
| Equity IFRS | CurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember | 2529985000 | JPY |
| Equity IFRS | CurrentQuarterInstant_OtherComponentsOfEquityIFRSMember | 3382697000 | JPY |
| Equity IFRS | Prior1YearInstant_EquityAttributableToOwnersOfParentIFRSMember | 20969692000 | JPY |
| Equity IFRS | Prior1YearInstant_NonControllingInterestsIFRSMember | -1158724000 | JPY |
| Equity IFRS | Prior1YearInstant | 19810968000 | JPY |
| Profit loss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | -2874000 | JPY |
| Profit loss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | -338870000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | -341745000 | JPY |
| Other comprehensive income IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 206546000 | JPY |
| Other comprehensive income IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | 78166000 | JPY |
| Other comprehensive income IFRS | CurrentYTDDuration | 284712000 | JPY |
| Comprehensive income IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 203671000 | JPY |
| Comprehensive income IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | -260704000 | JPY |
| Comprehensive income IFRS | CurrentYTDDuration | -57033000 | JPY |
| Issuance of new shares ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 3675000 | JPY |
| Issuance of new shares ss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | - | JPY |
| Issuance of new shares ss IFRS | CurrentYTDDuration | 3675000 | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | -21725000 | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | - | JPY |
| Forfeiture of share acquisition rights ss IFRS | CurrentYTDDuration | -21725000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember | 50245000 | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration_NonControllingInterestsIFRSMember | - | JPY |
| Share based payment transactions ss IFRS | CurrentYTDDuration | 50245000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |